TIAA CREF INVESTMENT MANAGEMENT LLC - THERAVANCE INC ownership

THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 127 filers reported holding THERAVANCE INC in Q3 2014. The put-call ratio across all filers is 1.82 and the average weighting 0.1%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of THERAVANCE INC
ValueSharesWeighting
Q4 2015$2,883,000
+39.9%
273,489
-4.7%
0.00%0.0%
Q3 2015$2,061,000
-61.5%
287,033
-3.2%
0.00%
-50.0%
Q2 2015$5,358,000
+17.1%
296,512
+1.9%
0.00%
+33.3%
Q1 2015$4,576,000
+9.9%
291,117
-1.1%
0.00%0.0%
Q4 2014$4,164,000
-21.7%
294,249
-5.4%
0.00%
-25.0%
Q3 2014$5,316,000
-43.6%
311,037
-1.8%
0.00%
-42.9%
Q2 2014$9,431,000
+95.8%
316,694
+103.5%
0.01%
+133.3%
Q1 2014$4,816,000
-82.6%
155,652
-80.0%
0.00%
-85.0%
Q4 2013$27,703,000
-25.5%
777,072
-14.5%
0.02%
-31.0%
Q3 2013$37,177,000
+28.8%
909,205
+21.4%
0.03%
+20.8%
Q2 2013$28,866,000749,1810.02%
Other shareholders
THERAVANCE INC shareholders Q3 2014
NameSharesValueWeighting ↓
Baupost Group 20,395,056$607,365,0009.89%
Realm Partners LLC 301,521$8,979,0003.75%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 2,805,837$83,558,0002.52%
IRIDIAN ASSET MANAGEMENT LLC/CT 7,447,743$221,794,0002.27%
SECTORAL ASSET MANAGEMENT INC 1,743,188$51,912,0002.20%
Foundation Asset Management, LP 255,790$7,617,0002.19%
Proxima Capital Management, LLC 550,000$16,379,0001.93%
Roundview Capital LLC 140,645$4,188,0001.69%
BB BIOTECH AG 933,244$27,792,0001.32%
PERRY CAPITAL 1,517,208$45,182,0001.25%
View complete list of THERAVANCE INC shareholders